Stockreport

Avenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol [Yahoo! Finance]

Avenue Therapeutics, Inc.  (ATXI) 
Last avenue therapeutics, inc. earnings: 8/14 07:30 am Check Earnings Report
PDF focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that it has reached final agreement with the U.S. [Read more]